Ro60-0175 is a drug developed by Hoffmann–La Roche, which has applications in scientific research.[1][2] It acts as a potent and selective agonist for both the 5-HT2B and 5-HT2C serotonin receptor subtypes, with good selectivity over the closely related 5-HT2A subtype, and little or no affinity at other receptors.[3][4]
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
ChemSpider |
|
UNII |
|
ChEBI |
|
ECHA InfoCard | 100.189.524 |
Chemical and physical data | |
Formula | C11H12ClFN2 |
Molar mass | 226.68 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |